141 related articles for article (PubMed ID: 8286848)
1. Signaling pathways for vitamin D-induced differentiation: implications for therapy of proliferative and neoplastic diseases.
Studzinski GP; McLane JA; Uskoković MR
Crit Rev Eukaryot Gene Expr; 1993; 3(4):279-312. PubMed ID: 8286848
[TBL] [Abstract][Full Text] [Related]
2. Signaling of monocytic differentiation by a non-hypercalcemic analog of vitamin D3, 1,25(OH)2-5,6 trans-16-ene-vitamin D3, involves nuclear vitamin D receptor (nVDR) and non-nVDR-mediated pathways.
Ji Y; Wang X; Donnelly RJ; Uskokovic MR; Studzinski GP
J Cell Physiol; 2002 May; 191(2):198-207. PubMed ID: 12064463
[TBL] [Abstract][Full Text] [Related]
3. Role of nongenomic activation of phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase 1/2 pathways in 1,25D3-mediated apoptosis in squamous cell carcinoma cells.
Ma Y; Yu WD; Kong RX; Trump DL; Johnson CS
Cancer Res; 2006 Aug; 66(16):8131-8. PubMed ID: 16912191
[TBL] [Abstract][Full Text] [Related]
4. Electrical responses to 1alpha,25(OH)2-Vitamin D3 and their physiological significance in osteoblasts.
Zanello LP; Norman AW
Steroids; 2004 Aug; 69(8-9):561-5. PubMed ID: 15288770
[TBL] [Abstract][Full Text] [Related]
5. A-ring analogues of 1, 25-(OH)2D3 with low affinity for the vitamin D receptor modulate chondrocytes via membrane effects that are dependent on cell maturation.
Greising DM; Schwartz Z; Posner GH; Sylvia VL; Dean DD; Boyan BD
J Cell Physiol; 1997 Jun; 171(3):357-67. PubMed ID: 9180905
[TBL] [Abstract][Full Text] [Related]
6. Effect of growth and maturation on membrane-initiated actions of 1,25-dihydroxyvitamin D3-II: calcium transport, receptor kinetics, and signal transduction in intestine of female chickens.
Larsson B; Nemere I
J Cell Biochem; 2003 Dec; 90(5):901-13. PubMed ID: 14624450
[TBL] [Abstract][Full Text] [Related]
7. Uncoupling of cell cycle arrest from the expression of monocytic differentiation markers in HL60 cell variants.
Studzinski GP; Rathod B; Wang QM; Rao J; Zhang F
Exp Cell Res; 1997 May; 232(2):376-87. PubMed ID: 9168815
[TBL] [Abstract][Full Text] [Related]
8. Up-regulation of Ca2+ influx mediated by store-operated channels in HL60 cells induced to differentiate by 1 alpha,25-dihydroxyvitamin D3.
Gardner JP; Balasubramanyam M; Studzinski GP
J Cell Physiol; 1997 Sep; 172(3):284-95. PubMed ID: 9284948
[TBL] [Abstract][Full Text] [Related]
9. Hybrid structural analogues of 1,25-(OH)2D3 regulate chondrocyte proliferation and proteoglycan production as well as protein kinase C through a nongenomic pathway.
Boyan BD; Posner GH; Greising DM; White MC; Sylvia VL; Dean DD; Schwartz Z
J Cell Biochem; 1997 Sep; 66(4):457-70. PubMed ID: 9282324
[TBL] [Abstract][Full Text] [Related]
10. Plasma membrane requirements for 1alpha,25(OH)2D3 dependent PKC signaling in chondrocytes and osteoblasts.
Boyan BD; Wang L; Wong KL; Jo H; Schwartz Z
Steroids; 2006 Apr; 71(4):286-90. PubMed ID: 16325216
[TBL] [Abstract][Full Text] [Related]
11. Cyclin-dependent kinase inhibitor p27 as a mediator of the G1-S phase block induced by 1,25-dihydroxyvitamin D3 in HL60 cells.
Wang QM; Jones JB; Studzinski GP
Cancer Res; 1996 Jan; 56(2):264-7. PubMed ID: 8542578
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D analogs, 20-Epi-22-oxa-24a,26a,27a,-trihomo-1alpha,25(OH)2-vitamin D3, 1,24(OH)2-22-ene-24-cyclopropyl-vitamin D3 and 1alpha,25(OH)2-lumisterol3 prime NB4 leukemia cells for monocytic differentiation via nongenomic signaling pathways, involving calcium and calpain.
Berry DM; Meckling-Gill KA
Endocrinology; 1999 Oct; 140(10):4779-88. PubMed ID: 10499538
[TBL] [Abstract][Full Text] [Related]
13. 1,25-Dihydroxyvitamin D3 induced activation and subsequent nuclear translocation of MAPK is upstream regulated by PKC in HL-60 cells.
Marcinkowska E; Wiedłocha A; Radzikowski C
Biochem Biophys Res Commun; 1997 Dec; 241(2):419-26. PubMed ID: 9425286
[TBL] [Abstract][Full Text] [Related]
14. Physician Education: The Erythropoietin Receptor and Signal Transduction.
Yoshimura A; Arai K
Oncologist; 1996; 1(5):337-339. PubMed ID: 10388012
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D resistance.
Bouillon R; Verstuyf A; Mathieu C; Van Cromphaut S; Masuyama R; Dehaes P; Carmeliet G
Best Pract Res Clin Endocrinol Metab; 2006 Dec; 20(4):627-45. PubMed ID: 17161336
[TBL] [Abstract][Full Text] [Related]
16. 1alpha,25-dihydroxyvitamin D3 stimulates phosphorylation of IkappaBalpha and synergizes with TPA to induce nuclear translocation of NFkappaB during monocytic differentiation of NB4 leukemia cells.
Berry DM; Clark CS; Meckling-Gill KA
Exp Cell Res; 2002 Jan; 272(2):176-84. PubMed ID: 11777342
[TBL] [Abstract][Full Text] [Related]
17. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK
J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138
[TBL] [Abstract][Full Text] [Related]
18. Subcellular localisation of BAG-1 and its regulation of vitamin D receptor-mediated transactivation and involucrin expression in oral keratinocytes: implications for oral carcinogenesis.
Lee SS; Crabb SJ; Janghra N; Carlberg C; Williams AC; Cutress RI; Packham G; Hague A
Exp Cell Res; 2007 Sep; 313(15):3222-38. PubMed ID: 17662274
[TBL] [Abstract][Full Text] [Related]
19. The vitamin D receptor.
Carlberg C; Seuter S
Dermatol Clin; 2007 Oct; 25(4):515-23, viii. PubMed ID: 17903610
[TBL] [Abstract][Full Text] [Related]
20. Carnosic acid potentiates the antioxidant and prodifferentiation effects of 1alpha,25-dihydroxyvitamin D3 in leukemia cells but does not promote elevation of basal levels of intracellular calcium.
Danilenko M; Wang Q; Wang X; Levy J; Sharoni Y; Studzinski GP
Cancer Res; 2003 Mar; 63(6):1325-32. PubMed ID: 12649194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
